Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Glutamine and antioxidants in critically ill patients.

Heyland D, Wischmeyer PE, Day AG; Canadian Clinical Care Trials Group.

N Engl J Med. 2013 Aug 1;369(5):484-5. doi: 10.1056/NEJMc1306658. No abstract available.

PMID:
23902496
[PubMed - indexed for MEDLINE]
Free Article
2.

Glutamine and antioxidants in critically ill patients.

Buijs N, Vermeulen MA, van Leeuwen PA.

N Engl J Med. 2013 Aug 1;369(5):484. doi: 10.1056/NEJMc1306658#SA4. No abstract available.

PMID:
23902500
[PubMed - indexed for MEDLINE]
3.

Glutamine and antioxidants in critically ill patients.

Pasin L, Landoni G, Zangrillo A.

N Engl J Med. 2013 Aug 1;369(5):482-4. doi: 10.1056/NEJMc1306658#SA3. No abstract available.

PMID:
23902499
[PubMed - indexed for MEDLINE]
4.

Glutamine and antioxidants in critically ill patients.

Rodgers MG, van Meurs M, Zijlstra JG.

N Engl J Med. 2013 Aug 1;369(5):482. doi: 10.1056/NEJMc1306658#SA2. No abstract available.

PMID:
23902498
[PubMed - indexed for MEDLINE]
5.

Glutamine and antioxidants in critically ill patients.

Bistrian BR.

N Engl J Med. 2013 Aug 1;369(5):482. doi: 10.1056/NEJMc1306658#SA1. No abstract available.

PMID:
23902497
[PubMed - indexed for MEDLINE]
6.

Glutamine in critically ill patients.

Chakraborty N, Poddar B.

Natl Med J India. 2013 Mar-Apr;26(2):94-5. No abstract available.

PMID:
24093985
[PubMed - indexed for MEDLINE]
7.

[Intensive care: does administration of glutamine and antioxidants make sense? Supplementation of glutamine only in special cases].

Hecker M, Mayer K.

Dtsch Med Wochenschr. 2013 Jun;138(25-26):1344. doi: 10.1055/s-0032-1329051. Epub 2013 Jun 12. German. No abstract available.

PMID:
23761055
[PubMed - indexed for MEDLINE]
8.

Low glutamine levels during critical illness--adaptive or maladaptive?

Van den Berghe G.

N Engl J Med. 2013 Apr 18;368(16):1549-50. doi: 10.1056/NEJMe1302301. No abstract available.

PMID:
23594008
[PubMed - indexed for MEDLINE]
9.

A randomized trial of glutamine and antioxidants in critically ill patients.

Heyland D, Muscedere J, Wischmeyer PE, Cook D, Jones G, Albert M, Elke G, Berger MM, Day AG; Canadian Critical Care Trials Group.

N Engl J Med. 2013 Apr 18;368(16):1489-97. doi: 10.1056/NEJMoa1212722. Erratum in: N Engl J Med. 2013 May 9;368(19):1853. Dosage error in article text..

PMID:
23594003
[PubMed - indexed for MEDLINE]
Free Article
10.

Monitoring the clinical introduction of a glutamine and antioxidant solution in critically ill trauma and burn patients.

Soguel L, Chioléro RL, Ruffieux C, Berger MM.

Nutrition. 2008 Nov-Dec;24(11-12):1123-32. doi: 10.1016/j.nut.2008.05.024. Epub 2008 Aug 9.

PMID:
18692364
[PubMed - indexed for MEDLINE]
11.

REducing Deaths due to OXidative Stress (The REDOXS Study): Rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically-ill patients.

Heyland DK, Dhaliwal R, Day AG, Muscedere J, Drover J, Suchner U, Cook D; Canadian Critical Care Trials Group.

Proc Nutr Soc. 2006 Aug;65(3):250-63. Review.

PMID:
16923310
[PubMed - indexed for MEDLINE]
12.

Optimizing the dose of glutamine dipeptides and antioxidants in critically ill patients: a phase I dose-finding study.

Heyland DK, Dhaliwalm R, Day A, Drover J, Cote H, Wischmeyer P.

JPEN J Parenter Enteral Nutr. 2007 Mar-Apr;31(2):109-18.

PMID:
17308251
[PubMed - indexed for MEDLINE]
13.

Intestinal permeability and systemic infections in critically ill patients: effect of glutamine.

De-Souza DA, Greene LJ.

Crit Care Med. 2005 May;33(5):1125-35. Review.

PMID:
15891348
[PubMed - indexed for MEDLINE]
14.

Early enteral supplementation with key pharmaconutrients improves Sequential Organ Failure Assessment score in critically ill patients with sepsis: outcome of a randomized, controlled, double-blind trial.

Beale RJ, Sherry T, Lei K, Campbell-Stephen L, McCook J, Smith J, Venetz W, Alteheld B, Stehle P, Schneider H.

Crit Care Med. 2008 Jan;36(1):131-44.

PMID:
18007263
[PubMed - indexed for MEDLINE]
15.

Growth hormone to catabolic patients revisited.

Wernerman J.

Crit Care Med. 2008 Jun;36(6):1952-3. doi: 10.1097/CCM.0b013e318176aa4a. No abstract available.

PMID:
18520646
[PubMed - indexed for MEDLINE]
16.

The effect of N-acetylcysteine on total serum anti-oxidant potential and urinary albumin excretion in critically ill patients.

Molnar Z, MacKinnon KL, Shearer E, Lowe D, Watson ID.

Intensive Care Med. 1998 Mar;24(3):230-5.

PMID:
9565804
[PubMed - indexed for MEDLINE]
17.

Clinical use of glutamine supplementation.

Wernerman J.

J Nutr. 2008 Oct;138(10):2040S-2044S. Review.

PMID:
18806121
[PubMed - indexed for MEDLINE]
Free Article
18.

Metabolic support of the critically ill: 2008 update.

Iapichino G, Radrizzani D, Destrebecq A, Vincenzi M, Zanello M.

Minerva Anestesiol. 2008 Dec;74(12):709-13. Epub 2008 Jul 18. Review.

PMID:
18636056
[PubMed - indexed for MEDLINE]
19.

Tolerability and efficacy of a low-volume enteral supplement containing key nutrients in the critically ill.

Schneider A, Markowski A, Momma M, Seipt C, Luettig B, Hadem J, Wilhelmi M, Manns MP, Wedemeyer J.

Clin Nutr. 2011 Oct;30(5):599-603. doi: 10.1016/j.clnu.2011.04.003. Epub 2011 May 31.

PMID:
21621886
[PubMed - indexed for MEDLINE]
20.

Exogenous glutamine--compensating a shortage?

Tjader I, Berg A, Wernerman J.

Crit Care Med. 2007 Sep;35(9 Suppl):S553-6. Review.

PMID:
17713408
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk